Lexaria (LEXX): Total Asset Value of Company

Graphic logo of lexariabioscience.com (LEXX)

Lexaria Bioscience (LEXX) laboratory capacities operate under a stable planning regime, while the production of trial drug batches is automated through partner plants. The company is developing a targeted drug delivery system to increase the speed of therapy efficacy for diabetes and hypertension. This chart illustrates that the asset's market value is 5.76, highlighting the value of the DehydraTECH licensing model with minimal capital expenditures.

Lexaria Bioscience Corp. (LEXX) Company Total Assets: for the period 07/04/2022 - 10/27/2026

Comprehensive metric breakdowns and analytics for lexariabioscience.com (LEXX)

- price and consensus price forecast:
Share Price Lexaria Bioscience Corp.|LEXX - Price Target Chart
- market capitalization data:
Market Valuation Lexaria Bioscience Corp.|LEXX - Enterprise Value
- book capitalization data:
Accounting Value of a Share Lexaria Bioscience|LEXX - Book Capitalization|Market Capitalization to Book Value Ratio lexariabioscience.com|LEXX - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Lexaria Bioscience|LEXX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Lexaria Bioscience Corp.|LEXX - Company Aggregate Debts|Debts to Book Capitalization Lexaria Bioscience Corp.
Fundamental valuation:LEXX, Lexaria
Finished products of Lexaria Bioscience Corp

Professional managers utilize fundamental metrics to identify hidden business degradation, assessing total resources through a reverse ROA calculation. The total asset dynamics of Lexaria Bioscience (LEXX) reflect the company's ability to scale its innovative DehydraTECH technology, where asset growth must validate the development of drug delivery systems rather than increase financial vulnerability amid stagnant revenue.

Competitors of Lexaria Bioscience (LEXX)

HLN (haleon.com) - Total Business Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value ORMP (oramed.com)|Aggregate Company Assets Entera Bio ENTX|Aggregate Company Assets MindWalk Holdings, Inc. HYFT|ABVC (ABVC BioPharma Inc) - Company Total Assets|Cumberland Corp (CPIX) - Company Assets|Cumulative Company Assets Quantum BioPharma Ltd|fibrogen.com (FGEN) - Total Business Assets|TELO (Telomir Pharmaceuticals, Inc.) - Company Total Assets|Company Total Assets RANI|Synergy CHC Corp (SNYR) - Aggregate Company Assets|Aggregate Asset Value rallybio.com (RLYB)|Company Total Assets PULM|Company Total Asset Base Pheton Holdings Limited PTHL|Aptorum - Company Total Assets|Lyra Therapeutics Inc. (LYRA) - Company Total Assets|Cumulative Company Assets Impact BioMedical IBO|TNF Pharmaceuticals, Inc. (TNFA) - Aggregate Asset Value|Company Total Assets cbdMD Inc.|Aggregate Company Assets painreform.com|CYTO (Altamira Therapeutics) - Company Total Assets|Company Total Asset Base LIPO (Lipella Pharmaceuticals Inc)|OPTN: Aggregate Company Assets|Pieris Pharma - Company Assets|Aggregate Company Assets PROC (Procaps Group S.A.)|PTPI - Company Total Asset Base|QLI (Qilian International Holding) - Company Total Assets|Acelyrin Inc. (SLRN) - Cumulative Company Assets|TFFP: Company Total Assets